Search For "monoclonal antibody"
Intas and Henlius receive positive CHMP opinion for HETRONIFLY® (HANS
Updated : 1 year, 7 months ago IST
Ahmedabad (Gujarat) [India], September 25: Intas Pharmaceuticals Limited ("Intas") has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of HETRONIFLY® (serplulimab, approve
Read More
Zumutor Biologics Announces Dosing of First Patient with ZM008, a First-in
Updated : 1 year, 10 months ago IST
Boston (Massachusetts) [US]/ Bangalore (Karnataka) [India], June 12: Zumutor Biologics Inc. "Zumutor", a Boston-based clinical stage Oncology Company developing first-in-class monoclonal antibody molecules targeting innate immunological pathways, today announced that the first patient was do
Read More
Nipah virus: India to source 20 more doses of monoclonal antibody from Aus
Updated : 2 years, 7 months ago IST
ICMR Director General Dr Rajiv Bahl said that no one has been so far been administered the medicine in India, further highlighting that the medicine needs to be given during the early stage of the infection.
Read More
Zumutor Biologics Inc announces FDA clearance of IND application of ZM008,
Updated : 2 years, 8 months ago IST
Boston [US]/Bangalore (Karnataka) [India], August 11: Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces that the US Food and Drug Administration (FDA) has granted the company's In
Read More
Study sheds light on immunotherapy treatment for ALS
Updated : 7 months ago IST
A type of monoclonal antibody that has already been tested in cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological disease.
Read More
Study gives more insight into immunotherapy treatment for ALS
Updated : 2 years, 9 months ago IST
A type of monoclonal antibody that has already been tried in certain types of cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological illness.
Read More
Researchers find dupilumab reduces disease in COPD patients with type 2 in
Updated : 2 years, 10 months ago IST
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.
Read More
Immunotherapy could be effective for treatment of prostate cancer: Study
Updated : 3 years ago IST
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
Read More
Study finds how novel immunotherapy helps fight against high-risk prostat
Updated : 3 years ago IST
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
Read More
Research finds how antibody therapy impacts COVID vaccines
Updated : 3 years, 4 months ago IST
Nearly three years into the pandemic, many of us now carry antibodies against the virus--due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses are created equal, and how we first developed our antibodies may influen
Read More
New treatment for atopic dermatitis shows promising result
Updated : 3 years, 4 months ago IST
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers report
Read More
Anifrolumab has shown long-term efficiency in lupus patients: Study
Updated : 3 years, 5 months ago IST
Type I interferon (IFN) is a strong immune activator found in high concentrations in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the first placebo-controlled long-term trial of anifrolumab, a human mon
Read More